RE: 5 reasons to have a good, hard, long look at POLB1 Jun 2026 15:02
I very much agree with your analysis BurtonD. They're on the verge of starting a phase 2 trial with interest from J&J and active support/engagement. I heard Professor John Bell, the immunotherapy expert who supported and guided the covid trials, on radio 4 on Saturday. He predicted that immunotherapy will displace chemo in the end and boost our longevity in general, since scientists are understanding and providing strong evidence bases for a generic impact on our wider health from these treatments. He said it could have huge implications for the NHS and help us move away from a model based largely on responding to acute or chronic medical need to one of prevention helping to reduce health inequalities. But of course CRS needs to be addressed decisively before that can ever materialise fully and at scale. It's quite amazing how far we've come.
Not sure what investors are waiting for. The price is being moved up now on very little volume so I suspect that is happening for a reason.